Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

VYNE Therapeutics Inc. - Common Stock (NQ:VYNE)

1.380 -0.050 (-3.50%)
Streaming Delayed Price Updated: 1:13 PM EDT, Apr 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 165,876
Open 1.450
Bid (Size) 1.370 (14)
Ask (Size) 1.380 (2)
Prev. Close 1.430
Today's Range 1.360 - 1.540
52wk Range 1.280 - 4.300
Shares Outstanding 51,511,845
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
Top stock movements in today's session.
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill

Performance

YTD
-58.6%
-58.6%
1 Month
-18.8%
-18.8%
3 Month
-49.8%
-49.8%
6 Month
-51.4%
-51.4%
1 Year
-47.5%
-47.5%

More News

Read More
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
VYNE Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Via Benzinga
Forecasting The Future: 4 Analyst Projections For VYNE Therapeutics
Via Benzinga
Analyst Scoreboard: 4 Ratings For VYNE Therapeutics
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
FDA Puts VYNE Therapeutics Early-Stage Psoriasis Study On Hold
Via Benzinga
Exposures Product Safety
These stocks that are showing activity before the opening bell on Friday.
Via Chartmill
Recap: VYNE Therapeutics Q4 Earnings
Via Benzinga
Recap: VYNE Therapeutics Q3 Earnings
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
VYNE Stock Earnings: VYNE Therapeutics Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
VYNE Stock Earnings: VYNE Therapeutics Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Top 4 Health Care Stocks That May Rocket Higher In Q1
Via Benzinga
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Dow Surges Over 500 Points; Western Digital Announces Plan To Split Into Two Companies
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Positive Momentum For VYNE Therapeutics' Psoriasis, Rheumatoid Arthritis Candidate - Analyst Expresses Encouragement
Via Benzinga
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga

Frequently Asked Questions

Is VYNE Therapeutics Inc. - Common Stock publicly traded?
Yes, VYNE Therapeutics Inc. - Common Stock is publicly traded.
What exchange does VYNE Therapeutics Inc. - Common Stock trade on?
VYNE Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for VYNE Therapeutics Inc. - Common Stock?
The ticker symbol for VYNE Therapeutics Inc. - Common Stock is VYNE on the Nasdaq Stock Market
What is the current price of VYNE Therapeutics Inc. - Common Stock?
The current price of VYNE Therapeutics Inc. - Common Stock is 1.380
When was VYNE Therapeutics Inc. - Common Stock last traded?
The last trade of VYNE Therapeutics Inc. - Common Stock was at 04/28/25 01:13 PM ET
What is the market capitalization of VYNE Therapeutics Inc. - Common Stock?
The market capitalization of VYNE Therapeutics Inc. - Common Stock is 71.09M
How many shares of VYNE Therapeutics Inc. - Common Stock are outstanding?
VYNE Therapeutics Inc. - Common Stock has 71M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.